13-48045806-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1
The NM_018283.4(NUDT15):c.*7G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0649 in 1,559,978 control chromosomes in the GnomAD database, including 3,840 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.055 ( 349 hom., cov: 32)
Exomes 𝑓: 0.066 ( 3491 hom. )
Consequence
NUDT15
NM_018283.4 3_prime_UTR
NM_018283.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.178
Genes affected
NUDT15 (HGNC:23063): (nudix hydrolase 15) This gene encodes an enzyme that belongs to the Nudix hydrolase superfamily. Members of this superfamily catalyze the hydrolysis of nucleoside diphosphates, including substrates like 8-oxo-dGTP, which are a result of oxidative damage, and can induce base mispairing during DNA replication, causing transversions. The encoded enzyme is a negative regulator of thiopurine activation and toxicity. Mutations in this gene result in poor metabolism of thiopurines, and are associated with thiopurine-induced early leukopenia. Multiple pseudogenes of this gene have been identified. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 13-48045806-G-A is Benign according to our data. Variant chr13-48045806-G-A is described in ClinVar as [Benign]. Clinvar id is 3055414.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUDT15 | NM_018283.4 | c.*7G>A | 3_prime_UTR_variant | 3/3 | ENST00000258662.3 | NP_060753.1 | ||
NUDT15 | NR_136687.2 | n.523G>A | non_coding_transcript_exon_variant | 3/5 | ||||
NUDT15 | NR_136688.2 | n.516+7G>A | splice_region_variant, intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUDT15 | ENST00000258662.3 | c.*7G>A | 3_prime_UTR_variant | 3/3 | 1 | NM_018283.4 | ENSP00000258662.1 |
Frequencies
GnomAD3 genomes AF: 0.0555 AC: 8442AN: 152058Hom.: 346 Cov.: 32
GnomAD3 genomes
AF:
AC:
8442
AN:
152058
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0695 AC: 14340AN: 206292Hom.: 742 AF XY: 0.0664 AC XY: 7507AN XY: 113044
GnomAD3 exomes
AF:
AC:
14340
AN:
206292
Hom.:
AF XY:
AC XY:
7507
AN XY:
113044
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0659 AC: 92729AN: 1407800Hom.: 3491 Cov.: 30 AF XY: 0.0648 AC XY: 45276AN XY: 698966
GnomAD4 exome
AF:
AC:
92729
AN:
1407800
Hom.:
Cov.:
30
AF XY:
AC XY:
45276
AN XY:
698966
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0555 AC: 8440AN: 152178Hom.: 349 Cov.: 32 AF XY: 0.0586 AC XY: 4359AN XY: 74398
GnomAD4 genome
AF:
AC:
8440
AN:
152178
Hom.:
Cov.:
32
AF XY:
AC XY:
4359
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
80
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
NUDT15-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 11, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at